Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IGHV3-21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemia.

European journal of haematology - 1 Feb 2010

Mansouri Mahmoud R, Sevov Marie, Aleskog Anna, Jondal Mikael, Merup Mats, Sundström Christer, Osorio Lyda, Rosenquist Richard

Abstract excerpt

T-cell leukemia/lymphoma protein 1 (TCL1) was recently shown to display an expression pattern in chronic lymphocytic leukemia (CLL) corresponding to molecular subtypes, where poor-risk patients demonstrated higher expression levels. Here, we examined the mRNA expression pattern of TCL1 in 144 pat...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Gene Expression Regulation, Leukemic
Share to Immunoglobulin Heavy Chains

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoglobulin Variable Region

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Proto-Oncogene Proteins

Share to RNA, Messenger

Share to Survival Rate

Source

Identifiers

PMID: 19889012
DOI: 10.1111/j.1600-0609.2009.01369.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19889012-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IGHV3-21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemia.PMID 19889012Read ↗

The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study.Semantic proximity Read ↗

Expression of Mutated IGHV3-23 Genes in Chronic Lymphocytic Leukemia Identifies a Disease Subset with Peculiar Clinical and Biological FeaturesSemantic proximity Read ↗

IGHV3-21 gene frequency in a Swedish cohort of patients with newly diagnosed chronic lymphocytic leukemia.Semantic proximity Read ↗

Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study.Semantic proximity Read ↗

IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine.Semantic proximity Read ↗

Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.Semantic proximity Read ↗

Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia.Semantic proximity Read ↗

V(H)3-21 gene usage in chronic lymphocytic leukemia--characterization of a new subgroup with distinct molecular features and poor survival.Semantic proximity Read ↗

Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia.Semantic proximity Read ↗

Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia.Semantic proximity Read ↗

Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia.Semantic proximity Read ↗

Use of IGHV3–21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post–germinal center leukemogenic selectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.